跳至主要内容
临床试验/NCT06710743
NCT06710743已完成不适用

Determination of the Glycemic Index Values of 10 Cereal-based Products

PepsiCo Global R&D1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2024年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
10
试验地点
1
主要终点
Glycemic index (GI) values

研究概览

简要总结

To determine the Glycemic index values for 10 cereal-based products

详细描述

To determine the Glycemic index values for 10 cereal-based products per international standard (ISO26642:2010) for glycemic index determination.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •10 healthy participants, male and female (non-pregnant, non-lactating) of mixed ethnicity, aged between 18 - 65 y
  • •BMI: 18 - 25.0 kg/m2 (bounds included)
  • •Non smokers
  • •Normal glucose tolerance (assessed by 50 gram oral glucose tolerance test performed within the last 30 days: fasting <6 mM, 2 hr glucose <7.8 mM)
  • •Stable weight and dietary habits. Normal eating patterns and no history of eating disorders or recent dieting
  • •Normal sleep patterns (ie. at least 6 hours of sleep per night)
  • •The participants are required to avoid alcohol and unusual levels of food intake and physical activity for the 24 hours before each test session.
  • •Absence of health conditions that would prevent fulfillment of study requirements as judged by the Investigator on the basis of medical history. Understanding the study procedures and willing to provide informed consent to participate in the study and authorization to release relevant protected health information to the study investigator.

排除标准

  • •Food allergy or intolerance to the study ingredients (eg. gluten, etc.)
  • •Regularly taking prescription medication other than standard contraceptive medication
  • •Taking any medications known to affect glucose tolerance (eg. acetylsalicylic acid, thyroxin, vitamins and mineral supplements or drugs to treat hypertension or osteoporosis)
  • •Suffering from any illness or disease
  • •Following a restricted diet
  • •Eating disorders
  • •Abnormal glucose tolerance or known history of diabetes mellitus.
  • •Individuals currently participating in other acute metabolic studies
  • •Failure to meet any one of the inclusion criteria

研究组 & 干预措施

Reference food

Active Comparator

Glucodin powder solution

干预措施: Glucose solution Day 1, Day 8, and Day 15 (Other)

Food 1

Experimental

Quaker Whole Oats

干预措施: Food (cereal). Ten different cereals served once each (Other)

Food 8

Experimental

Jowar Flakes

干预措施: Food (cereal). Ten different cereals served once each (Other)

Food 2

Experimental

Quaker Quick Cooking White Oats

干预措施: Food (cereal). Ten different cereals served once each (Other)

Food 3

Experimental

Saffola Oats

干预措施: Food (cereal). Ten different cereals served once each (Other)

Food 4

Experimental

Quaker Oats

干预措施: Food (cereal). Ten different cereals served once each (Other)

Food 5

Experimental

Quaker Oats Multigrain

干预措施: Food (cereal). Ten different cereals served once each (Other)

Food 6

Experimental

Ragi Flakes

干预措施: Food (cereal). Ten different cereals served once each (Other)

Food 7

Experimental

Bajra Flakes

干预措施: Food (cereal). Ten different cereals served once each (Other)

Food 9

Experimental

Maltabella

干预措施: Food (cereal). Ten different cereals served once each (Other)

Food 10

Experimental

FutureLife Smart + White Oats

干预措施: Food (cereal). Ten different cereals served once each (Other)

结局指标

主要结局

Glycemic index (GI) values

时间窗: Two hour test session per visit. Visits must be at least two days apart. Including Screening, the study duration is approximately four to eleven weeks depending on whether participants are available to be tested one, two or three times per week.

Comparison of Glycemic index (GI) values of 10 different cereal-based products and the reference food (glucose solution assigned GI=100 by definition)

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验